Recent NRIX Stock Price | NRIX Stock Predictions | |
$12.73 | +92.07% |
$24.45 |
Recent NRIX Analyst Ratings Breakdown, Making NRIX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 8 | 8 | 8 | 9 |
Buy ratings: | 2 | 2 | 2 | 2 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.36 | 1.36 | 1.36 | 1.33 |
For the NRIX stock predictions from the analysts covering Nurix Therapeutics Inc, we have collected all of the individual NRIX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 11 different analysts covering NRIX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NRIX stock predictions may vary widely, another useful metric to consider is the median NRIX stock prediction, which represents the price at which half of the analysts
made NRIX stock predictions that were higher and half made NRIX stock predictions that were lower. This makes for a different take on the NRIX stock predictions out there, as compared to average or mean.
And that median across all the individual NRIX stock predictions was: $25.0 as of 2024-05-03.
The very highest of the NRIX stock predictions for one year price target was $35.0, while the very lowest of the NRIX stock predictions in the analyst group was
$14.0 (with a standard deviation of $6.105). Get the latest Zacks research report on NRIX — FREE
Find out: NRIX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ELP Stock Predictions
NUVA Stock Predictions
CYRX Stock Predictions
VIRT Stock Predictions
ECOM Stock Predictions
DXR Stock Predictions
ESTA Stock Predictions
AQN Stock Predictions
OTEX Stock Predictions
|
|
Strong Buy (3.64 out of 4) 67th percentile
(ranked higher than approx. 67% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |